Relationship between germline MC1R variants and BRAF-mutant melanoma in a North Carolina population-based study.

[1]  M. Eccles,et al.  PAX3 Is extensively expressed in benign and malignant tissues of the melanocytic lineage in humans. , 2010, The Journal of investigative dermatology.

[2]  N. Hayward,et al.  The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population. , 2010, The Journal of investigative dermatology.

[3]  D. Elder,et al.  MC1R variants increase risk of melanomas harboring BRAF mutations. , 2008, The Journal of investigative dermatology.

[4]  D. Duffy,et al.  Red hair is the null phenotype of MC1R , 2008, Human mutation.

[5]  F. Sera,et al.  MC1R variants, melanoma and red hair color phenotype: A meta‐analysis , 2008, International journal of cancer.

[6]  R. Millikan,et al.  CDKN2A germline mutations in individuals with cutaneous malignant melanoma. , 2007, The Journal of investigative dermatology.

[7]  R. Millikan,et al.  Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[8]  R. Millikan,et al.  Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. , 2006, Cancer research.

[9]  D. Pinkel,et al.  MC1R germline variants confer risk for BRAF-mutant melanoma. , 2006, Science.

[10]  D. Pinkel,et al.  MC1R Germline Variants Confer Risk for BRAF-Mutant Melanoma , 2006, Science.

[11]  R. Millikan,et al.  A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. , 2006, International journal of epidemiology.

[12]  Wei Chen,et al.  Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. , 2003, Human molecular genetics.

[13]  R. Willemze,et al.  Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. , 2001, The Journal of investigative dermatology.